生物医学转化
Lanzhou University Press · China
Aims & Scope
Biomedical Transformation(CN 62-1218/R; ISSN 2096-8965) wasfoundedon July 3, 2020, with the approval oftheChineseNational Press and Publication Administration, and officially launched on December 30, 2020. The journal isgoverned bythe Ministry of Education, sponsored by Lanzhou University,and publishedby Lanzhou University Press. The editorial department is locatedinthe Second Hospital&Clinical Medical School,Lanzhou University. Biomedical Transformationpositions itself as aninnovativeandprofessional academic journal in thefield ofbiomedical and industrialtransformation.With the focus on"transformation", the journalis dedicated tostrengtheninghot research topics in biomedical research,publishing less explored areas, and playinga flagship and leading role in the industry.The journalpublishesnew findings, methods and technologies inthe fields ofbasic biological research, clinical research, biotreatment, biopharmaceutical R&D and clinical transformation, with theaimofpromotingacademic exchange, advancingthe development of biomedicine and clinical transformation, and servingthe Healthy ChinaInitiative. Theregular columnsof the journal includeCommentaries,SpecialTopics,OriginalResearch,Review,Clinical&TranslationalMedicine,NewBiotechnologies,CaseReport,ExpertConsensus,Science&TechnologyGovernance,News, andCoverStory. The intended readership includes experts andscholarsin the fields of medicine, biological sciences and biology, as well as medical staff at various clinical departments, health and medical technology personnel, and scientific researchersinmedical schools and institutions. The Editorial Board ofBiomedical Transformationis composed ofmanydistinguishedexperts,includingAcademiciansof the Chinese Academy of Sciences and the Chinese Academy of Engineering, Chair Professors of the Yangtze River Scholars, recipients of the National Science Fund for Distinguished Young Scholars, awardees of the National Natural Science Foundation's Excellent Young Scientist Fund, rec
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Frequently asked questions about 生物医学转化
Is 生物医学转化 a predatory journal?
PubScope has no integrity flags on record for 生物医学转化: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of 生物医学转化?
生物医学转化 is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is 生物医学转化 indexed in Scopus and Web of Science?
生物医学转化 is indexed in DOAJ.
What is the aims and scope of 生物医学转化?
Biomedical Transformation(CN 62-1218/R; ISSN 2096-8965) wasfoundedon July 3, 2020, with the approval oftheChineseNational Press and Publication Administration, and officially launched on December 30, 2020. The journal isgoverned bythe Ministry of Education, sponsored by Lanzhou University,and publishedby Lanzhou University Press. The editorial department is locatedinthe Second Hospital&Clinical Medical School,Lanzhou University. Biomedical Transformationpositions itself as aninnovativeandprofessional academic journal in thefield ofbiomedical and industrialtransformation.With the focus on"trans
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref